Acquisitions (Fair Values Of The Assets Acquired And Liabilities) (Details) (USD $) In Millions, unless otherwise specified	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011 Beckman Coulter	Jun. 30, 2011 Beckman Coulter	Dec. 31, 2010 AB Sciex & Molecular Devices	Jan. 30, 2010 AB Sciex & Molecular Devices	Dec. 31, 2011 Others	Dec. 31, 2010 Others
Business Acquisition [Line Items]
Trade accounts receivable	$ 105.4	$ 859.5	$ 178.7	$ 783.3		$ 102.7		$ 76.2	$ 76.0
Inventories	97.0	812.4	171.2	774.0		104.3		38.4	66.9
Property, plant and equipment	87.5	1,042.1	84.8	1,036.2		54.5		5.9	30.3
Goodwill	1,015.7	4,164.7	1,157.8	3,745.8		496.9		418.9	660.9
Other intangible assets, primarily trade names, customer relationships and patents	768.3	2,772.4	870.9	2,518.0		342.0		254.4	528.9
In-process research and development	61.5	143.0	26.5	143.0		7.4		0	19.1
Trade accounts payable	(50.8)	(278.2)	(59.6)	(257.3)		(37.9)		(20.9)	(21.7)
Other assets and liabilities, net	(287.7)	(1,662.9)	(238.4)	(1,561.0)		(30.7)		(101.9)	(207.7)
Assumed debt	0	(1,640.4)	(0.9)	(1,640.4)		(0.9)		0	0
Non-controlling interest acquired	(0.1)	(1.8)	(61.3)	0		0		(1.8)	(61.3)
Net cash consideration	$ 1,796.8	$ 6,210.8	$ 2,129.7	$ 5,541.6	$ 5,500.0	$ 1,038.3	$ 1,000.0	$ 669.2	$ 1,091.4